<DOC>
	<DOC>NCT00321321</DOC>
	<brief_summary>The investigators hypothesize that the impaired insulinotropic effect of the incretin hormone GIP may be due to inadequate sensitization and ATP induced closure of beta cell K-ATP channels. By closing the channels through the use of sulfonylurea (SU) we hope to restore the insulinotropic effect of GIP.</brief_summary>
	<brief_title>The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<criteria>Type 2 diabetes mellitus diagnosed according to WHO criteria Diet and/or metformin treatment HbA1c &gt; 7,0% for metformin treated patients HbA1c &gt; 7,5% for diet treated patients Age: 18 years or older 25 &gt; BMI &gt; 40 kg/m2 Signed informed consent Sufficient birth control in case of child bearing capacity Proliferative retinopathy Diabetic nephropathy with screatinine &gt; 130 microM and/or macroalbuminuria Liver disease (ALAT &gt; 2 x normal value) CAD (NYHA group III or IV) Positive screening for isletcell and/or GAD65 autoantibodies Type 1 diabetes i first degree relatives Gastrointestinal surgery with intestinal resection Anemia Pregnancy and/or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Glucose dependent insulinotropic polypeptide</keyword>
	<keyword>Sulfonylurea compounds</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>Sulfonylurea receptor subunit-SUR1</keyword>
	<keyword>Impaired incretin effect</keyword>
</DOC>